Case Reports

  1. H E TWINING, H M DIXON, F D WEIDMAN. Penicillin in treatment of Madura foot; report of two cases. U S Nav Med Bull. 1946;46:417–29. Available from: https://pubmed.ncbi.nlm.nih.gov/21012952/
  2. MITRA SK. A case of madura foot treated with penicillin. Indian medical gazette. 1946;81:82.
  3. Hassani ME El, Babahabib A, Kouach J, Kassidi F, Houari Y El, Moussaoui D, et al. Actinomycose pelvienne pseudo tumorale associée au dispositif intra-utérin: à propos de trois cas. Pan Afr Med J. 2014;19. Available from: /pmc/articles/PMC4335282/
  4. Tight RR, Bartlett MS. Actinomycetoma in the United States. Rev Infect Dis. 1981;3(6):1139–50. Available from: https://academic.oup.com/cid/article/3/6/1139/313709
  5. GREEN WO, ADAMS TE. Mycetoma in the United States: A Review and Report of Seven Additional Cases. Am J Clin Pathol. 1964;42(1):75–91. Available from: https://academic.oup.com/ajcp/article/42/1/75/1763240
  6. Wallace RJ, Vance P, Weissfeld A, Martin RR. Beta-Lactamase Production and Resistance to Beta-Lactam Antibiotics in Nocardia. Antimicrob Agents Chemother. 1978;14(5):704. Available from: /pmc/articles/PMC352537/?report=abstract
  7. Ameen M, Arenas R, Vásquez del Mercado E, Fernández R, Torres E, Zacarias R. Efficacy of imipenem therapy for Nocardia actinomycetomas refractory to sulfonamides. J Am Acad Dermatol. 2010;62(2):239–46. Available from: https://pubmed.ncbi.nlm.nih.gov/20005007/
  8. Fuentes A, Arenas R, Reyes M, Fernández RF, Zacarías R. Actonomycetoma and Nocardia sp. Report of five cases treatedwith imipenem plus amikacin. Gac Med Mex. 2006;142(3):247–52. Available from: www.anmm.org.mx
  9. Fernadez RF, Arenas R. Imipenem. An alternative treatment for actinomycetoma: an appraisal. . Monogr Dermatol. 2006;19:48-54.
  10. Adán Fuentes, Roberto Arenas, Miguel Reyes, Ramón F Fernández, Rogelio Zacarías. [Actinomycetoma and Nocardia sp. Report of five cases treated with imipenem or imipenem plus amikacin]. Gac Med Mex . 2006;142(3):247–52. Available from: https://pubmed.ncbi.nlm.nih.gov/16875355/
  11. Dalhoff A, Nasu T, Okamoto K. Beta-lactamase stability of faropenem. Chemotherapy. 2003;49(5):229–36.
  12. Dixon JM. Sulfanilamide therapy in Madura foot  . Virginia M Monthly. 1941;68:281.
  13. Peters JT. A Clinical Cure of Madura Foot. American Journal of Tropical Medicine. 1945;25(4):363–5.
  14. Carlos CM. MADURA FOOT (MYCETOMA): First Report from the Isthmus of Panama. Arch Derm Syphilol. 1947;55(6):761–71. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/521588
  15. Benbow E, Smith D, Grimson K. Sulfonamide Therapy in Aetinomy-eosis. Two Cases caused by Aerobic partially Acid-fast Aetinomyees. American Review of Tuberculosis and Pulmonary Diseases. 1944;
  16. Green R, Bolton TC, Woolsey CI. Mycetoma—Madura Foot : A Case of Mycetoma Pedis in Chicago. Ann Surg. 1948;128(5):1015. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513913/
  17. H P Hogshead, G H Stein. Mycetoma due to Nocardia brasiliensis. J Bone Joint Surg Am . 1970;52(6):1229–34. Available from: https://pubmed.ncbi.nlm.nih.gov/4989461/
  18. Long PI, Campana HA. An Unusual Mycetoma. Arch Dermatol. 1966;93(3):341–5. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/529661
  19. White EA, Patel DB, Forrester DM, Gottsegen CJ, O’Rourke E, Holtom P, et al. Madura foot: Two case reports, review of the literature, and new developments with clinical correlation. Skeletal Radiol. 2014;43(4):547–53. Available from: https://link.springer.com/article/10.1007/s00256-013-1751-z
  20. Halde C, Ringrose EJ. Mycetoma originating in northern California; disease caused by a fungus resembling nocardia madurae. AMA Arch Derm. 1956;74(1):80–5. Available from: https://pubmed.ncbi.nlm.nih.gov/13325967/
  21. Neuhauser I. Black Grain Maduromycosis Caused by Madurella Grisea: Report of the First North American Case and Its Response to Therapy with Diaminodiphenylsulfone. AMA Arch Derm. 1955;72(6):550–5. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/524534
  22. VIPULYASEKHA S, VATHANABHUTI HS. Treatment of nocardial mycetoma with sulphamethoxypyridazine. Br J Dermatol. 1960;72(5):188–90. Available from: https://pubmed.ncbi.nlm.nih.gov/13842422/
  23. A T LONDERO. Ação do Sulfisoxazol na actinomicose provocada pelo Actinomyces brasiliensis [Sulfisoxazol in the treatment of mycetomas caused by Nocardia brasiliensis]. Hospital (Rio J) . 1962;62:187–9. Available from: https://pubmed.ncbi.nlm.nih.gov/14466437/
  24. M T Dieng, S O Niang, B Diop, B Ndiaye. [Actinomycetomas in Senegal: study of 90 cases]. Bull Soc Pathol Exot . 2005;98(1):18–20. Available from: https://pubmed.ncbi.nlm.nih.gov/15915967/
  25. Welsh O. Mycetoma Current Concepts in Treatment. Int J Dermatol. 1991;30(6):387–98. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-4362.1991.tb03892.x
  26. GONZALEZ OCHOA A. Effectiveness of DDS in the treatment of chromoblastomyeosis and of mycetoma caused by Nocardia brasilicnsis. , pp. 321-327. . in STERNBERG, T H, AND NEWCOMER, V D: Therapy of Fungus Diseases Bos- ton: Little, Brown & Company,. 1955;321–7.
  27. Berd D. Nocardia brasiliensis Infection in the United States: A Report of Nine Cases and a Review of the Literature. Am J Clin Pathol. 1973;60(2):254–8. Available from: https://academic.oup.com/ajcp/article/60/2/254/1765561
  28. A GONZALEZ OCHOA, M AHUMADA PADILLA. Treatment of actinomycotic mycetoma by local injection of diaminodiphenyl sulfone. Rev Inst Salubr Enferm Trop . 1958;18(1):41–4. Available from: https://pubmed.ncbi.nlm.nih.gov/13579574/
  29. Peter Cockshott W, Rankin AM. MEDICAL TREATMENT OF MYCETOMA. The Lancet. 1960;276(7160):1112–4.
  30. Rogers RS, Muller SA. Treatment of Actinomycetoma With Dapsone: A Report of Infection With Nocardia asteroides. Arch Dermatol. 1974;109(4):529–34. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/533901
  31. Gugnani HC, Suselan A V., Anikwe RM, Udeh FN, Ojukwu JO. Actinomycetoma in Nigeria. Journal of Tropical Medicine and Hygiene. 1981;84(6):259–63.
  32. González-Ochoa A, Little Brown Co. Effectiveness of DDS in the treatment of chromoblastomycosis and of mycetoma caused by Nocardia brasiliensis. In: In Therapy of fungus diseases, an international symposium. 1955. page 321–7.
  33. Kamalam A, Thambiah AS. A clinico-pathological study of actinomycotic mycetomas caused by Actinomadura madurae and Actinomadura pelletierii. Mycopathologia. 1987;97(3):151–63. Available from: https://pubmed.ncbi.nlm.nih.gov/3574438/
  34. W R Hubler Jr, W R Hubler. Actinomycotic mycetoma treated with minocycline: case report. Tex Med . 1976;72(8):79–83. Available from: https://pubmed.ncbi.nlm.nih.gov/951664/
  35. ZIPRKOWSKI L, ALTMANN G, DALITH F, SPITZ U. Mycetoma Pedis: Four Cases Treated with Streptomycin. AMA Arch Derm. 1957;75(6):855–63. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/525049
  36. Welsh O, Sauceda E, Gonzalez J, Ocampo J. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J Am Acad Dermatol. 1987;17(3):443–8. Available from: https://pubmed.ncbi.nlm.nih.gov/3308980/
  37. Welsh O, López R. Micetomas con diseminación pulmonar. Med Cutan Ibero Lat Am. 1985;13:517–23.
  38. Welsh O, Vera-Cabrera L, Salinas-Carmona MC. Current treatment for nocardia infections. https://doi.org/101517/146565662013842553. 2013;14(17):2387–98. Available from: https://www.tandfonline.com/doi/abs/10.1517/14656566.2013.842553
  39. Vázquez FL, Farrera CA, Juan MÁA, Vigil GP, Esponda FF, Guzmán RA. Actinomycetomas in Chiapas. A Report of 15 Cases at Centro Dermatológico del Sureste Dr. Fernando Latapí. Dermatología Cosmética, Médica y Quirúrgica. 2018;16(2):116–22.
  40. Patra S, Senthilnathan G, Ramam M, Arava S, Bhari N. Linezolid: A novel treatment option for the treatment of a non-responsive case of actinomycotic mycetoma. Indian J Dermatol Venereol Leprol. 2021;87(3):473–5. Available from: https://www.ijdvl.com/linezolid-a-novel-treatment-option-for-the-treatment-of-a-non-responsive-case-of-actinomycotic-mycetoma/
  41. Welsh O. Response to newer therapeutic modalities for actinomycetoma by Nocardia species. Int J Dermatol. 2018;57(9):e65–6. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/ijd.14070
  42. Moylett EH, Pacheco SE, Brown-Elliott BA, Perry TR, Buescher ES, Birmingham MC, et al. Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis. 2003;36(3):313–8. Available from: https://pubmed.ncbi.nlm.nih.gov/12539073/
  43. Popova TP, Ignatov I, Petrova T, Dinkov G, Zeng W. Antimicrobial Activity of Pregnenolone in vitro. J Pharm Res Int. 2021;33(1):61–7. Available from: http://www.medicalbiophysics.bg/en/31139.html
  44. Khan FA, Hashmi S, Sarwari AR. Multiple Subcutaneous Mycetomas caused by Pseudallescheria boydii: Response to therapy with oral potassium iodide solution. Journal of Infection. 2010;60(2):178–81.
  45. Christopherson JB. On the Treatment of the Actinomycosis Type of Mycetoma. J R Soc Med. 1928;21(3):471–4. Available from: https://journals.sagepub.com/doi/abs/10.1177/003591572802100358
  46. Latapí F. Study of 100 Cases of Mycetoma in Mexico City. Study of 100 Cases of Mycetoma in Mexico City. 1959;203–13.
  47. Alteras I, Feuerman EJ. The second case of mycetoma due to Nocardia caviae in Israel. Mycopathologia. 1986;93(3):185–7. Available from: https://pubmed.ncbi.nlm.nih.gov/3713800/
  48. S G NICOLAU, A AVRAM. [Contribution to the conservative treatment of mycetoma of the foot. Curative effect of isonicotinic acid hydrazide on several cases caused by parasites sensitive to such chemotherapy]. Probl Ter . 1959;10(2):61–8. Available from: https://pubmed.ncbi.nlm.nih.gov/14426983/
  49. Latapi F, P. Lavalle. Emploi des sulfones et de L’isoniazide dans le traitment des mycetomes. In: In VIII Congres International de Botanique. 1954.
  50. Borelli D, Leal J. Mycetoma by nocardia brasiliensis successfully treated with ethambutol. Trans R Soc Trop Med Hyg. 1969;63(6):881–2. Available from: https://academic.oup.com/trstmh/article/63/6/881/1910560
  51. Avram A. Etude sur les mycétomes de Roumanie. Mycopathol Mycol Appl. 1966;28(1–2):1–15. Available from: https://link.springer.com/article/10.1007/BF02276016
  52. Maniar SH, Anderson PG. Mycetoma caused by Nocardia brasiliensis in Missouri. Case report. Missouri Medicine  . 1966;63:273–5. Available from: https://www.cabdirect.org/cabdirect/abstract/19691303292
  53. Lamb JH, Kelly FC, Shackelford PO, Koons RC. Pregnenolone acetate in treatment of mycetoma (nocardiosis). AMA Arch Derm Syphilol. 1953;67(2):141–5. Available from: https://pubmed.ncbi.nlm.nih.gov/13029897/
  54. Bergeron JR, Mullins JF, Ajello L. Mycetoma Caused by Nocardia pelletieri in the United States. Arch Dermatol. 1969;99(5):564–6. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/530949
  55. R E Biagini, T E Martínez, A Museli, H Sarmiento Villa. [Mycetoma in northern Argentina]. Med Cutan Ibero Lat Am . 1983;11(6):431–6. Available from: https://pubmed.ncbi.nlm.nih.gov/6366400/
  56. Mahgoub ES. Treatment of actinomycetoma with sulphamethoxazole plus trimethoprim. Am J Trop Med Hyg. 1972;21(3):332–5. Available from: https://pubmed.ncbi.nlm.nih.gov/5025617/
  57. Maibach HI, Gorham W, Aly R. Nocardia brasiliensis Mycetoma: Treatment With Co-trimoxazole. Arch Dermatol. 1975;111(5):656–656. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/534989
  58. Nitidandhaprabhas P, Sittapairochana D. Treatment of Nocardial Mycetoma With Trimethoprim and Sulfamethoxazole. Arch Dermatol. 1975;111(10):1345–8. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/535428
  59. Hoffman TE, Russell B, Jacobs PH. Mycetoma-like Infection Caused by Previously Undescribed Bacterium. Arch Dermatol. 1978;114(8):1199–202. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/539087
  60. Saksun JM, Kane J, Schachter RK. Mycetoma caused by Nocardia madurae. Can Med Assoc J. 1978;119(8):911. Available from: /pmc/articles/PMC1819081/?report=abstract
  61. B Ndiaye, M Develoux, M A Langlade, A Kane. [Actinomycotic mycetoma. Apropos of 27 cases in Dakar; medical treatment with cotrimoxazole]. Ann Dermatol Venereol . 1994;121(2):161–5. Available from: https://pubmed.ncbi.nlm.nih.gov/7979030/
  62. Mirza SH, Campbell C. Mycetoma caused by Nocardia transvalensis. J Clin Pathol. 1994;47(1):85–6. Available from: https://pubmed.ncbi.nlm.nih.gov/8132817/
  63. Khatri ML, Al-Halali HM, Khalid MF, Saif SA, Vyas MCR. Mycetoma in Yemen: clinicoepidemiologic and histopathologic study. Int J Dermatol. 2002;41(9):586–93. Available from: https://pubmed.ncbi.nlm.nih.gov/12358829/
  64. Kapoor S, Khunger N, Jain RK, Dayal S, Mishra S, Capoor MR. Iatrogenic actinomycetoma of neck and back successfully treated with sulphonamides. Clin Exp Dermatol. 2007;32(1):95–6. Available from: https://academic.oup.com/ced/article/32/1/95/6624852
  65. Shamsadini S, Shamsi Meimandi S, Sadre Eshkavari S, Vahidreza S. Report of two cases of mycetoma in the Islamic Republic of Iran. East Mediterr Health J. 2007;13(5):1219–22. Available from: https://pubmed.ncbi.nlm.nih.gov/18290418/
  66. Metgud S, Sumati H, Sheetal P. Cutaneous actinomycosis: a rare case. Indian J Med Microbiol. 2007;25(4):413–5. Available from: https://pubmed.ncbi.nlm.nih.gov/18087099/
  67. Castro LGM, Piquero-Casals J. Clinical and mycologic findings and therapeutic outcome of 27 mycetoma patients from São Paulo, Brazil. Int J Dermatol. 2008;47(2):160–3. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-4632.2008.03447.x
  68. Carmen Padilla Desgarennes, V. C. Díaz. Micetoma por Actinomadura madurae en un paciente con tuberculosis pulmonar. Comunicación de un caso | Semantic Scholar. Dermatología (México, DF). 2009;53(3):145–9. Available from: https://www.semanticscholar.org/paper/Micetoma-por-Actinomadura-madurae-en-un-paciente-de-Desgarennes-D%C3%ADaz/93e62692906723b94b2d7042ffcc9c3988676ff5
  69. Magalhães GM, de Castro Oliveira SC, de Brito Soares AC, Machado-Pinto J, de Resende MA. Mycetoma caused by Nocardia caviae in the first Brazilian patient. Int J Dermatol. 2010;49(1):56–8. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-4632.2009.04263.x
  70. Carlson H. Case of the Month . JAAPA . 2011;24(5):79. Available from: https://journals.lww.com/jaapa/Citation/2011/05000/Case_of_the_Month.18.aspx
  71. Gomes J, Pereira T, Carvalho A, Brito C. Primary cutaneous actinomycosis caused by as first manifestation of HIV infection. Dermatol Online J. 2011;17(11). Available from: https://escholarship.org/uc/item/0n05580m
  72. Zúñiga M, Hunziker MF, Nico MM, Rivitti EA, Festa-Neto C. Actinomycetoma of the scalp due to Nocardia brasiliensis: case report and review of the literature. Int J Dermatol. 2015;54(6):695–8. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/ijd.12107
  73. Sampaio FMS, Wanke B, Freitas DFS, Coelho JMC de O, Galhardo MCG, Lyra MR, et al. Review of 21 cases of mycetoma from 1991 to 2014 in Rio de Janeiro, Brazil. PLoS Negl Trop Dis. 2017;11(2). Available from: https://pubmed.ncbi.nlm.nih.gov/28192433/
  74. Bitan O, Wiener-Well Y, Segal R, Schwartz E. Mycetoma (Madura Foot) in Israel: Recent Cases and a Systematic Review of the Literature. Am J Trop Med Hyg. 2017;96(6):1355. Available from: /pmc/articles/PMC5462571/
  75. Padhi S, Uppin SG, Uppin MS, Umabala P, Challa S, Laxmi V, et al. Mycetoma in South India: retrospective analysis of 13 cases and description of two cases caused by unusual pathogens: Neoscytalidium dimidiatum and Aspergillus flavus. Int J Dermatol. 2010;49(11):1289–96. Available from: https://pubmed.ncbi.nlm.nih.gov/20964650/
  76. Izri A, Aljundi M, Billard-Pomares T, Fofana Y, Marteau A, Ferreira TG, et al. Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report. BMC Infect Dis. 2020;20(1). Available from: https://pubmed.ncbi.nlm.nih.gov/33176717/
  77. Kébé M, Ba O, Mohamed Abderahmane MA, Mohamed Baba ND, Ball M, Fahal A. A study of 87 mycetoma patients seen at three health facilities in Nouakchott, Mauritania. Trans R Soc Trop Med Hyg. 2021;115(4):315–9. Available from: https://pubmed.ncbi.nlm.nih.gov/33580966/
  78. Kébé M, Ba O, Mohamed Abderahmane MA, Mohamed Baba ND, Ball M, Fahal A. A study of 87 mycetoma patients seen at three health facilities in Nouakchott, Mauritania. Trans R Soc Trop Med Hyg. 2021;115(4):315–9. Available from: https://pubmed.ncbi.nlm.nih.gov/33580966/
  79. Khatri ML, Al Kubati SAS, Gaffer IA, Abdel Majeed SM. Mycetoma in north-western Yemen: Clinico-epidemiological and histopathological study. Indian J Dermatol Venereol Leprol. 2022;88(5):615–22. Available from: https://pubmed.ncbi.nlm.nih.gov/35389029/
  80. Marc S, Meziane M, Hamada S, Hassam B, Benzekri L. Clinique et épidémiologie des mycétomes au Maroc. Med Mal Infect. 2011;41(3):163–4.
  81. Martinez RE, Couchel S, Swartz WM, Smith MB. Mycetoma of the hand. J Hand Surg Am. 1989;14(5):909–12. Available from: https://pubmed.ncbi.nlm.nih.gov/2677118/
  82. Harrington TL, Eldredge D, Benson EK. Immigration Brings New Pathology with No Standardized Treatment Protocol Madura Foot Case Studies Phialemonium and Phaeoacremonium. J Am Podiatr Med Assoc. 2018;108(6):517–22. Available from: https://pubmed.ncbi.nlm.nih.gov/30742501/
  83. Saül A, Bonifaz A, Messina M, Andrade R. Mycetoma due to Nocardia caviae. Int J Dermatol. 1987;26(3):174–7. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-4362.1987.tb00886.x
  84. I Kakande. Treatment of mycetoma with a combination of dapsone and co-trimoxazole – PubMed. East Afr Med J  . 1979;56(2):49–53. Available from: https://pubmed.ncbi.nlm.nih.gov/535536/
  85. Chávez G, Estrada R, Bonifaz A. Perianal actinomycetoma experience of 20 cases. Int J Dermatol. 2002;41(8):491–3. Available from: https://pubmed.ncbi.nlm.nih.gov/12207764/
  86. Myrna D, Acar R, Diana Sánchez D, Paulino DR, María D, Padilla C, et al. Micetoma podal por Nocardia brasiliensis.Reporte de un caso. Revista del Centro Dermatológico Pascua. 2004;13(1):37–40.
  87. Castillo, M. Padilla, G. Navarrete, Orieta Herbas, Ángela Aquino-Ruiz. Micetoma por Nocardia brasiliensis en región axilar. Presentación de un caso. Rev Cent Dermatol Pascua  . 2005;14(3):160–3. Available from: https://www.semanticscholar.org/paper/Micetoma-por-Nocardia-brasiliensis-en-regi%C3%B3n-de-un-Castillo-Padilla/32f9a7423a3e6e30c9000bb85252585e510e51ff
  88. Bonifaz A, Ibarra G, Saúl A, Paredes-Solis V, Carrasco-Gerard E, Fierro-Arias L. Mycetoma in children: experience with 15 cases. Pediatr Infect Dis J. 2007;26(1):50–2. Available from: https://pubmed.ncbi.nlm.nih.gov/17195706/
  89. Martha Pardo, Alexandro Bonifaz, Adriana Valencia, Javier Araiza, Silvia Anett Mejia, Carlos Mena-Cedillos. Actinomycetoma by Nocardia brasiliensis in a girl with Down syndrome – PubMed. Dermatol Online J . 2008;14(8):9. Available from: https://pubmed.ncbi.nlm.nih.gov/19061569/
  90. Tellez I, Franco-Paredes C. A Woman with Chronic Subcutaneous Swelling of the Right Foot Associated with Sinus Tracts Discharging Yellow Grains. PLoS Negl Trop Dis. 2010;4(9). Available from: /pmc/articles/PMC2956756/
  91. Bonifaz A, Tirado-Sánchez A, Vázquez-González D, Fierro-Arias L, Araiza J, González GM. Actinomycetoma by Actinomadura madurae. Clinical and therapeutic characteristics of 18 cases with two treatment modalities. https://doi.org/101080/0954663420201793887. 2020;1–5. Available from: https://www.tandfonline.com/doi/abs/10.1080/09546634.2020.1793887
  92. Kresch-Tronik NS, Carrillo-Casas EM, Arenas R, Atoche C, Del Río-Ávila C, Ochoa-Carrera LA, et al. First case of mycetoma associated with Nocardia takedensis. J Dermatol. 2013;40(2):135–6. Available from: https://pubmed.ncbi.nlm.nih.gov/23083296/
  93. Joshi R. Treatment of actinomycetoma with combination of rifampicin and co-trimoxazole. Indian J Dermatol Venereol Leprol. 2008;74(2):166. Available from: https://ijdvl.com/treatment-of-actinomycetoma-with-combination-of-rifampicin-and-co-trimoxazole/
  94. Banashankari GS, Rudresh HK, Sreeja S, Beena. Nocardial Mycetoma: Re-infection with a different species at an unusual site – A rare case. Indian J Pathol Microbiol. 2013;56(3):333. Available from: https://www.ijpmonline.org/article.asp?issn=0377-4929;year=2013;volume=56;issue=3;spage=333;epage=334;aulast=Banashankari
  95. Alteras I, Feuerman EJ, Dayan I. Mycetoma Due to Nocardia Caviae The First Israeli Patient. Int J Dermatol. 1980;19(5):260–2. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-4362.1980.tb00325.x
  96. Sardana K, Chugh S. Newer therapeutic modalities for Actinomycetoma by Nocardia species. Int J Dermatol. 2018;57(9):e64–5. Available from: https://pubmed.ncbi.nlm.nih.gov/29920651/
  97. Castro LGM, Belda W, Salebian A, Cucé LC. Mycetoma: a retrospective study of 41 cases seen in São Paulo, Brazil, from 1978 to 1989. Mycoses. 1993;36(3–4):89–95. Available from: https://pubmed.ncbi.nlm.nih.gov/8366881/
  98. Mitjà O, Hays R, Van Straten C, Robson J, Koka M, Bassat Q. Mycetoma caused by Nocardia yamanashiensis, Papua New Guinea. Am J Trop Med Hyg. 2012;86(6):1043–5. Available from: https://pubmed.ncbi.nlm.nih.gov/22665615/
  99. Ramam M, Bhat R, Garg T, Sharma VK, Ray R, Singh MK, et al. A modified two-step treatment for actinomycetoma. Indian J Dermatol Venereol Leprol. 2007;73(4):235–9. Available from: https://pubmed.ncbi.nlm.nih.gov/17675730/
  100. Palit A, Ragunatha S, Inamadar AC. Actinomycetoma: dramatic response to modified two-step regimen. Int J Dermatol. 2011;50(4):446–9. Available from: https://pubmed.ncbi.nlm.nih.gov/21413957/
  101. Agarwal US, Besarwal RK, Gupta R, Agarwal P. Treatment of actinomycetoma foot – our experience with ten patients. Journal of the European Academy of Dermatology and Venereology. 2013;27(12):1505–13. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.12036
  102. Xu XG, Zhang C, Qin J, Gao XH, Zhang L. A combination of trimethoprim/sulfamethoxazole with linezolid is useful for actinomycotic mycetoma: A summary of the existing data and the rationale of combination therapy. Indian J Dermatol Venereol Leprol. 2022;88(2):210–1. Available from: https://pubmed.ncbi.nlm.nih.gov/34877844/
  103. LastNameR Negroni, G López Daneri, A Arechavala, M H Bianchi, A M Robles. [Clinical and microbiological study of mycetomas at the Muñiz hospital of Buenos Aires between 1989 and 2004]. Rev Argent Microbiol . 2006;38(1):13–8. Available from: https://pubmed.ncbi.nlm.nih.gov/16784127/
  104. Bonifaz A, Tirado-sánchez A, Vazquez-gonzalez D, Araiza J, Hernández-castro R. Actinomycetoma by Actinomadura madurae: Clinical Characteristics and Treatment of 47 Cases. Indian Dermatol Online J. 2021;12(2):285. Available from: /pmc/articles/PMC8088182/
  105. Carlisle JT, Greer DL, Hyslop NE. Actinomycetoma of the Hand Caused by Nocardia asteroides. J Infect Dis. 1988;158(1):244–6. Available from: https://academic.oup.com/jid/article/158/1/244/787021
  106. Desgarennes M del CP, Vidal A. Micetoma en dorso por Nocardia brasiliensis. Comunicación de un caso. 2004;
  107. De Palma L, Marinelli M, Pavan M, Manso E, Ranaldi R. A rare European case of Madura Foot due to actinomycetes. Joint Bone Spine. 2006;73(3):321–4. Available from: https://pubmed.ncbi.nlm.nih.gov/16563843/
  108. Sharma N, Mahajan V, Agarwal S, Katoch V, Das R, Kashyap M, et al. Nocardial mycetoma: Diverse clinical presentations. Indian J Dermatol Venereol Leprol. 2008;74(6):635. Available from: https://ijdvl.com/nocardial-mycetoma-diverse-clinical-presentations/
  109. Welsh O, Morales-Toquero A, Cabrera-Vera L, Vazquez-Martinez O, Gómez-Flores M, Ocampo-Candiani J. Actinomycetoma of the scalp after a car accident. Int J Dermatol. 2011;50(7):854–7. Available from: https://pubmed.ncbi.nlm.nih.gov/21699522/
  110. Cordeiro FN, Bruno C, Reis C. Mycetoma. Am J Trop Med Hyg. 2011;85(5):791. Available from: /pmc/articles/PMC3205619/
  111. Vongphoumy I, Dance DAB, Dittrich S, Logan J, Davong V, Rattanavong S, et al. Case report: Actinomycetoma caused by Nocardia aobensis from Lao PDR with favourable outcome after short-term antibiotic treatment. PLoS Negl Trop Dis. 2015;9(4). Available from: https://pubmed.ncbi.nlm.nih.gov/25879445/
  112. de la Garza JAC, Welsh O, Cuéllar-Barboza A, Suarez-Sánchez KP, De la Cruz-Valadez E, Cruz-Gómez LG, et al. Clinical characteristics and treatment of actinomycetoma in northeast Mexico: A case series. PLoS Negl Trop Dis. 2020;14(2). Available from: https://pubmed.ncbi.nlm.nih.gov/32097417/
  113. Wang R, Yao X, Li R. Mycetoma in China: A Case Report and Review of the Literature. Mycopathologia. 2019;184(2):327–34. Available from: https://link.springer.com/article/10.1007/s11046-019-00324-z
  114. Taneja J, Passi S, Ranjan R, Abbas SZ, Ramesh V. Mycetoma by Nocardia blacklockiae: The first case. Indian J Med Microbiol. 2022;
  115. D K Damle, P M Mahajan, S N Pradhan, V A Belgaumkar, A P Gosavi, S N Tolat, et al. Modified Welsh regimen: a promising therapy for actinomycetoma . J Drugs Dermatol  . 2008;7(9):853–6. Available from: https://pubmed.ncbi.nlm.nih.gov/19112799/
  116. Ibarra-Morales D, Quiroz-García A, Gutiérrez G, Arellano-Mendoza M, Bonifaz A, Ibarra-Morales D, et al. Actinomicetoma torácico con afección pulmonar. Tratamiento con carbapenémico y aminoglucósido. Medicina interna de México. 2018;34(1):136–41. Available from: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0186-48662018000100015&lng=es&nrm=iso&tlng=es
  117. Patil SP, Gautam MM, Sodha AA, Khan KJ. Primary cutaneous nocardiosis with craniocerebral extension: A case report. Dermatol Online J. 2009;15(6).
  118. Saarinen KA, Lestringant GG, Czechowski J, Frossard PM. Cutaneous nocardiosis of the chest wall and pleura–10-year consequences of a hand actinomycetoma. Dermatology. 2001;202(2):131–3. Available from: https://pubmed.ncbi.nlm.nih.gov/11306835/
  119. Cazzato G, Colagrande A, Cimmino A, Lospalluti L, Demarco A, Foti C, et al. Skin Mycetoma in an 11-Year-Old African Boy: Case Presentation with Emphasis on Histopathological Features and Differential Diagnosis. Dermatopathology. 2021;8(4):509. Available from: /pmc/articles/PMC8628697/
  120. Gugnani HC, Sehgal VN, Singh VK, Boiron P, Kumar S. ‘Nocardia asteroides’ mycetoma of the foot. Journal of the European Academy of Dermatology and Venereology. 2002;16(6):640–2. Available from: https://onlinelibrary.wiley.com/doi/full/10.1046/j.1468-3083.2002.00653_3.x
  121. Joseph NM, Harish BN, Sistla S, Thappa DM, Parija SC. Streptomyces bacteremia in a patient with actinomycotic mycetoma. J Infect Dev Ctries. 2010;4(4):249–52. Available from: https://pubmed.ncbi.nlm.nih.gov/20440064/
  122. Ramam M, Garg T, D’Souza P, Verma KK, Khaitan BK, Singh MK, et al. A two-step schedule for the treatment of actinomycotic mycetomas. Acta Derm Venereol. 2000;80(5):378–80. Available from: https://pubmed.ncbi.nlm.nih.gov/11200840/
  123. Kar S, Prasad K, Madke B, Gangane N, Singh N. Abdomino-pelvic actinomycetoma successfully treated with combination chemotherapy. Australasian Journal of Dermatology. 2014;55(3):230–2. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/ajd.12211
  124. Reading C, Cole M. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977;11(5):852–7. Available from: https://pubmed.ncbi.nlm.nih.gov/879738/
  125. GOMEZ A, SAUL A, BONIEAZ A, LOPEZ M. Amoxicillin and clavulanic acid in the treatment of actinomycetoma. Int J Dermatol. 1993;32(3):218–20. Available from: https://pubmed.ncbi.nlm.nih.gov/8444539/
  126. Bonifaz A, Flores P, Saúl A, Carrasco-Gerard E, Ponce RM. Treatment of actinomycetoma due to Nocardia spp. with amoxicillin-clavulanate. Br J Dermatol. 2007;156(2):308–11. Available from: https://pubmed.ncbi.nlm.nih.gov/17223871/
  127. Seol CA, Sung H, Kim DH, Ji M, Chong YP, Kim MN. The first Korean case of disseminated mycetoma caused by Nocardia pseudobrasiliensis in a patient on long-term corticosteroid therapy for the treatment of microscopic polyangiitis. Ann Lab Med. 2013;33(3):203–7. Available from: https://pubmed.ncbi.nlm.nih.gov/23667849/
  128. Tsaqilah L, Marlysa L, Miliawati R. Oral Amoxicillin Clavulanic Acid as Systemic Therapy in a Patient Suspected with Actinomycetoma. 2021;451–5.
  129. Musa EA, Abdoon IH, Bakhiet SM, Osman B, Abdalla SA, Fahal AH. Mycetoma management and clinical outcomes: the Mycetoma Research Center experience. Trans R Soc Trop Med Hyg. 2023;117(1):12–21. Available from: https://academic.oup.com/trstmh/article/117/1/12/6651442
  130. Joana Antunes, David Pacheco, Rita Travassos, Hortênsia Sequeira, Paulo Filipe, Manuel Sacramento Marques. Actinomycetoma of the chest wall attributed to Nocardia nova after reconstructive surgery -. Dermatol Online J . 2012;18(1):4. Available from: https://pubmed.ncbi.nlm.nih.gov/22301041/
  131. Ameen M, Vargas F, Arenas R, Mercado EV del. Successful treatment of Nocardia actinomycetoma with meropenem and amikacin combination therapy. Int J Dermatol. 2011;50(4):443–5. Available from: https://pubmed.ncbi.nlm.nih.gov/21413956/
  132. Baril L, Boiron P, Manceron V, Ely SOO, Jamet P, Favre E, et al. Refractory craniofacial actinomycetoma due to Streptomyces somaliensis that required salvage therapy with amikacin and imipenem. Clin Infect Dis. 1999;29(2):460–1. Available from: https://pubmed.ncbi.nlm.nih.gov/10476772/
  133. Zaldo JBL, Ortega A, Amaral JA, Esqueda PG. Micetoma abdominal, manifestación inusual tratada con imipenem y amikacina. Med Int Mex . 2013;29(4):436–41.
  134. L J Méndez-Tovar, L Serrano-Jaén, V M Almeida-Arvizu. [Combined cefotaxime and amikacin for immunomodulation in the treatment of actinomycetoma resistant to conventional treatment] – PubMed. Gac Med Mex  Sep-Oct;:. 1999;135(5):517–21. Available from: https://pubmed.ncbi.nlm.nih.gov/10596493/
  135. Sharma N, Mendiratta V, Sharma RC, Hemal U, Verma M. Pulse therapy with amikacin and dapsone for the treatment of actinomycotic foot: a case report. J Dermatol. 2003;30(10):742–7. Available from: https://pubmed.ncbi.nlm.nih.gov/14684958/
  136. Al-Kathiri L, Al-Najjar T, Al-Asmaili A. Successful Treatment of Recalcitrant Actinomycetoma of Gluteal Area with Combined Medical Treatment and Surgical Excision with Graft Reconstruction. Oman Med J. 2020;35(2):e111. Available from: /pmc/articles/PMC7157440/
  137. HARJAT MM, SHARMA A, PANAYCH J, MENON P, NAGPAL B, SINGH Y. ACTINOMYCETOMA OF HAND AND FOOT. Med J Armed Forces India. 2000;56(3):252. Available from: /pmc/articles/PMC5532084/
  138. Kashima M, Kano R, Mikami Y, Takahama H, Ito M, Hasegawa A, et al. A successfully treated case of mycetoma due to Nocardia veterana. Br J Dermatol. 2005;152(6):1349–52. Available from: https://pubmed.ncbi.nlm.nih.gov/15949008/
  139. Kresch-Tronik NS, Carrillo-Casas EM, Arenas R, Atoche C, Ochoa-Carrera LA, Xicohtencatl-Cortes J, et al. Nocardia harenae, an uncommon causative organism of mycetoma: report on two patients. J Med Microbiol. 2012;61(Pt 8):1153–5. Available from: https://pubmed.ncbi.nlm.nih.gov/22499778/
  140. Chi MH, Hui RCY, Lu CF, Yang LC, Li SY. Actinomycetoma caused by Nocardia otitidiscaviarum: Report of a case in Taiwan with long-term follow-up. Dermatologica Sinica. 2013;31(3):149–53.
  141. Seabury JH, McGinn M, Salvaggio J. Mycetoma mandibularis due to Nocardia pelletieri. Am J Med. 1973;55(6):846–50.
  142. Adhikari L, Dey S, Pal R. Mycetoma due to Nocardia farcinica. J Glob Infect Dis. 2010;2(2):194. Available from: /pmc/articles/PMC2889662/
  143. Mattioni S, Develoux M, Brun S, Martin A, Jaureguy F, Naggara N, et al. Management of mycetomas in France. Med Mal Infect. 2013;43(7):286–94. Available from: https://pubmed.ncbi.nlm.nih.gov/23916308/
  144. Hung YT, Wu TS, Hsueh YH, Wang HN, Sun PL. Actinomycetoma caused by Nocardia brasiliensis successfully treated with antibiotics: A case report. Dermatologica Sinica. 2021;39(3):139. Available from: https://www.dermsinica.org/article.asp?issn=1027-8117;year=2021;volume=39;issue=3;spage=139;epage=140;aulast=Hung
  145. Bonifaz A, Espinosa-Díaz S, Argáez J, Hernández-Castro R, Xicohtencatl-Cortes J, Tirado-Sánchez A. Actinomycetoma due to Nocardia brasiliensis with extension to the ovaries. Eur J Obstet Gynecol Reprod Biol. 2017;211(4):224–5. Available from: http://www.ejog.org/article/S0301211517300957/fulltext
  146. Fahal AH, Rahman IA, El-Hassan AM, Rahman MEAEL, Zijlstra E. The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. Trans R Soc Trop Med Hyg. 2011;105(3):127–32. Available from: https://academic.oup.com/trstmh/article/105/3/127/1861396
  147. Fahal AH, Rahman IA, El-Hassan AM, Rahman MEAEL, Zijlstra E. The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. Trans R Soc Trop Med Hyg. 2011;105(3):127–32. Available from: https://academic.oup.com/trstmh/article/105/3/127/1861396
  148. Cavassin FB, Baú-Carneiro JL, Vilas-Boas RR, Queiroz-Telles F. Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections. Infectious Diseases and Therapy 2021 10:1. 2021;10(1):115–47. Available from: https://link.springer.com/article/10.1007/s40121-020-00382-7
  149. Magana M. Mycetoma. Int J Dermatol. 1984;23(4):221–36. Available from: https://pubmed.ncbi.nlm.nih.gov/6376380/
  150. Dubey N, Capoor MR, Hasan AS, Gupta A, Ramesh V, Sharma S, et al. Epidemiological profile and spectrum of neglected tropical disease eumycetoma from Delhi, North India. Epidemiol Infect. 2019;147:e294. Available from: https://www.cambridge.org/core/journals/epidemiology-and-infection/article/epidemiological-profile-and-spectrum-of-neglected-tropical-disease-eumycetoma-from-delhi-north-india/A65E128752FFBF41657786DAA7FBE0E7
  151. Sampaio FMS, Galhardo MCG, De Farias Cardoso R, de Oliveira Coelho JMC, Lyra MR, do Valle ACF. Eumycetoma on the foot caused by Madurella mycetomatis: amputation after significant worsening during pregnancy. Acta Derm Venereol. 2015;95(3):374–5. Available from: https://pubmed.ncbi.nlm.nih.gov/25178425/
  152. Mir F, Shakoor S, Khan MJ, Minhas K, Zafar A, Zaidi AKM. Madurella mycetomatis as an agent of brain abscess: case report and review of literature. Mycopathologia. 2013;176(5–6):429–34. Available from: https://pubmed.ncbi.nlm.nih.gov/24085615/
  153. Vilela R, Duarte OMV, Rosa CA, Castro JGF, Lyon S, Motta RL, et al. A case of eumycetoma due to Madurella grisea in northern Brazil. Mycopathologia. 2004;158(4):415–8. Available from: https://pubmed.ncbi.nlm.nih.gov/15630550/
  154. Veraldi S, Grancini A, Venegoni L, Merlo V, Guanziroli E, Menicanti C, et al. Mycetoma Caused by Aspergillus nidulans. Acta Derm Venereol. 2016;96(1):118–9. Available from: https://pubmed.ncbi.nlm.nih.gov/26014969/
  155. Kotwal N, Yanamandra U, Badwal S, Nair V. Mycetoma foot caused by Aspergillus in a diabetic patient. Intern Med. 2012;51(5):517–8. Available from: https://pubmed.ncbi.nlm.nih.gov/22382571/
  156. Hay RJ, Mahgoub ES, Leon G, Al-Sogair S, Welsh O. Mycetoma. Med Mycol. 1992;30(S1):41–9.
  157. Winter WG. Amphotericin B and Maduromycosis. American Journal of Diseases of Children. 1978;132(10):1045–1045. Available from: https://jamanetwork.com/journals/jamapediatrics/fullarticle/508168
  158. Thadepalli H, Salem FA, Mandal AK, Rambhatla K, Einstein HE. Pulmonary Mycetoma due to Coccidioides immitis. Chest. 1977;71(3):429–30.
  159. West BC, Kwon-Chung KJ. Mycetoma Caused by Microsporum audouinii: First Reported Case. Am J Clin Pathol. 1980;73(3):447–54. Available from: https://academic.oup.com/ajcp/article/73/3/447/1772559
  160. Rohatgi PK, Schmitt RG. Pulmonary Coccidioidal Mycetoma. Am J Med Sci. 1984;287(3):27–30.
  161. Ausina Ruiz V, Verger Garau G, Roig Boronat JL. [Autochthonous mycetoma caused by Petriellidium boydii (author’s transl)]. Med Clin (Barc). 1981;77(5):216–9. Available from: https://europepmc.org/article/med/7199107
  162. Itani Z, Ebert L, Greither A. [Mycetoma: attempt at intra-arterial management]. Hautarzt. 1981;32(6):345–9.
    • Mycetoma in children . Mod Probl Paediatr . 1975;17:248–53. Available from: https://pubmed.ncbi.nlm.nih.gov/1186681/
  163. Diaz M, Negroni R, Montero-Gei F, Castro LGM, Sampaio SAP, Borelli D, et al. A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group. Clin Infect Dis. 1992;14 Suppl 1:S68–76. Available from: https://pubmed.ncbi.nlm.nih.gov/1562698/
  164. Tóth EJ, Nagy GR, Homa M, Ábrók M, Kiss I, Nagy G, et al. Recurrent Scedosporium apiospermum mycetoma successfully treated by surgical excision and terbinafine treatment: A case report and review of the literature. Ann Clin Microbiol Antimicrob. 2017;16(1):1–9. Available from: https://ann-clinmicrob.biomedcentral.com/articles/10.1186/s12941-017-0195-z
  165. Mahgoub ES, Gumaa SA. Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. Trans R Soc Trop Med Hyg. 1984;78(3):376–9. Available from: https://pubmed.ncbi.nlm.nih.gov/6087513/
  166. J Auböck, E Pichler, P Fritsch. [Mycetoma caused by Petriellidium boydii: treatment with ketoconazole] – PubMed. Hautarzt  . 1985;36(8):453–8. Available from: https://pubmed.ncbi.nlm.nih.gov/4044257/
  167. J M Andreu. [Value of ketoconazole in combination with the surgical treatment of fungal mycetoma] – PubMed. Chirurgie . 1986;112(2):163–9. Available from: https://pubmed.ncbi.nlm.nih.gov/3677908/
  168. Stierstorfer MB, Schwartz BK, Mcguire JB, Miller AC. Pseudallescheria boydii mycetoma in northern New England. Int J Dermatol. 1988;27(6):383–7. Available from: https://pubmed.ncbi.nlm.nih.gov/3229880/
  169. Venucopal P V., Venugopal T V., Laing WN, Humaidan Y Al, Namnyak SS, Jama AA Al, et al. Black Grain Mycetoma Caused by Madurella grisea in Saudi Arabia. Int J Dermatol. 1990;29(6):434–5. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-4362.1990.tb03832.x
  170. Baudraz-Rosselet F, Monod M, Borradori L, Ginalsky JM, Vion B, Boccard C, et al. Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole. Dermatology. 1992;184(4):303–5. Available from: https://pubmed.ncbi.nlm.nih.gov/1498403/
  171. I Alteras, J Hagler, A Trattner, G Morojinski, R Segal, M Sandbank. [Mycetoma with black granules: first case in a native of Israel] . Hautarzt  . 1992;43(7):446–7. Available from: https://pubmed.ncbi.nlm.nih.gov/1506204/
  172. Venugopal P V., Venugopal T V. Treatment of eumycetoma with ketoconazole. Australas J Dermatol. 1993;34(1):27–9. Available from: https://pubmed.ncbi.nlm.nih.gov/8240184/
  173. Janaki C, Sentamilselvi G, Janaki VR, Devesh S, Ajithados K. Case report. Eumycetoma due to Curvularia lunata. Mycoses. 1999;42(4):345–6. Available from: https://pubmed.ncbi.nlm.nih.gov/10424108/
  174. Capoor M, Khanna G, Nair D, Hasan A, Rajni, Deb M, et al. Eumycetoma pedis due to Exophiala jeanselmei. Indian J Med Microbiol. 2007;25(2):155–7. Available from: https://pubmed.ncbi.nlm.nih.gov/17582190/
  175. García Rodrǐguez LA, Duque A, Castellsague J, Pérez-Gutthann S, Stricker BHC. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol. 1999;48(6):847–52. Available from: https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-suspension-marketing-authorisations-oral-ketoconazole
  176. FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems | FDA. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-limits-usage-nizoral-ketoconazole-oral-tablets-due-potentially
  177. European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole | European Medicines Agency. Available from: https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-suspension-marketing-authorisations-oral-ketoconazole
  178. A G Buiting, L G Visser, R M Barge, J W van ’t Wout. [Mycetoma of the foot; a disease from the tropics] – PubMed. Ned Tijdschr Geneeskd . 1993;137(30):1513–5. Available from: https://pubmed.ncbi.nlm.nih.gov/8396207/
  179. Lee MW, Kim JC, Choi JS, Kim KH, Greer DL. Mycetoma caused by Acremonium falciforme: successful treatment with itraconazole. J Am Acad Dermatol. 1995;32(5 Pt 2):897–900. Available from: https://pubmed.ncbi.nlm.nih.gov/7722053/
  180. Resnik BI, Burdick AE. Improvement of eumycetoma with itraconazole. J Am Acad Dermatol. 1995;33(5 Pt 2):917–9. Available from: https://pubmed.ncbi.nlm.nih.gov/7593811/
  181. B Degavre, J M Joujoux, M Dandurand, B Guillot. First report of mycetoma caused by Arthrographis kalrae: successful treatment with itraconazole – PubMed. J Am Acad Dermatol  . 1997;37(2):318–20. Available from: https://pubmed.ncbi.nlm.nih.gov/9270537/
  182. Smith EL, Kutbi S, Resnik BI, Burdick AE. Improvement of eumycetoma with itraconazole. J Am Acad Dermatol. 1997;36(2 Pt 1):279–80. Available from: https://pubmed.ncbi.nlm.nih.gov/9039190/
  183. A Paugam, C Tourte-Schaefer, A Keïta, N Chemla. Clinical cure of fungal madura foot with oral itraconazole – PubMed. Cutis . 1997;60(4):191–3. Available from: https://pubmed.ncbi.nlm.nih.gov/9347233/
  184. Severo LC, Vetoratto G, Oliveira F de M, Londero AT. Eumycetoma by Madurella grisea. Report of the first case observed in the southern Brazilian region. Rev Inst Med Trop Sao Paulo. 1999;41(2):139–42. Available from: https://pubmed.ncbi.nlm.nih.gov/10413963/
  185. Young BA, Fee MJ, Giacopelli JA, Granoff DP, Kobayashi W. Mycetoma. J Am Podiatr Med Assoc. 2000;90(2):81–4. Available from: https://pubmed.ncbi.nlm.nih.gov/10697972/
  186. Fletcher CL, Moore MK, Hay RJ. Eumycetoma due to Madurella mycetomatis acquired in Jamaica. Br J Dermatol. 2001;145(6):1018–21. Available from: https://pubmed.ncbi.nlm.nih.gov/11899126/
  187. Dikhaye S, Afifi Y, Aoufi S, Tligui H, Mirrane H, Senouci K, et al. [Mycetoma]. Ann Dermatol Venereol. 2008;135(8–9):626–8. Available from: https://pubmed.ncbi.nlm.nih.gov/18789306/
  188. Motswaledi HM, Mathekga K, Sein PP, Nemutavhanani DL. Paecilomyces lilacinus eumycetoma. Int J Dermatol. 2009;48(8):858–61. Available from: https://pubmed.ncbi.nlm.nih.gov/19659864/
  189. Bonifaz A, Hoog S, Mcginnis M, Saúl A, Rodríguez-Cortés O, Araiza J, et al. Eumycetoma caused by Cladophialophora bantiana successfully treated with itraconazole. Med Mycol. 2009;47(1):111–4. Available from: https://pubmed.ncbi.nlm.nih.gov/19031337/
  190. Estrada-Chavez GE, Vega-Memije ME, Arenas R, Chavez-Lopez G, Estrada-castañon R, Fernandez R, et al. Eumycotic mycetoma caused by Madurella mycetomatis successfully treated with antifungals, surgery, and topical negative pressure therapy. Int J Dermatol. 2009;48(4):401–3. Available from: https://pubmed.ncbi.nlm.nih.gov/19335427/
  191. Fahal AH, Rahman IA, El-Hassan AM, Rahman MEAEL, Zijlstra E. The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. Trans R Soc Trop Med Hyg. 2011;105(3):127–32. Available from: https://pubmed.ncbi.nlm.nih.gov/21247608/
  192. Iriart X, Binois R, Fior A, Blanchet D, Berry A, Cassaing S, et al. Eumycetoma caused by Diaporthe phaseolorum (Phomopsis phaseoli): a case report and a mini-review of Diaporthe/Phomopsis spp invasive infections in humans. Clin Microbiol Infect. 2011;17(10):1492–4. Available from: https://pubmed.ncbi.nlm.nih.gov/21781209/
  193. MacHmachi H, Godineau N, Develoux M, Bretagne S, Bazeli A, Amsellem D, et al. Black grain mycetoma caused by Leptosphaeria tompkinsii. Med Mycol. 2011;49(2):186–9. Available from: https://pubmed.ncbi.nlm.nih.gov/21235319/
  194. Campos-Macías P, Arenas-Guzmán R, Hernández-Hernández F. Fusarium subglutinans: A new eumycetoma agent. Med Mycol Case Rep. 2013;2(1):128–31.
  195. Verma R, Vasudevan B, Sahni AK, Vijendran P, Neema S, Kharayat V. First reported case of Aspergillus nidulans eumycetoma in a sporotrichoid distribution. Int J Dermatol. 2015;54(1):74–7. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/ijd.12571
  196. Al-Hatmi AMS, Bonifaz A, Tirado-Sánchez A, Meis JF, de Hoog GS, Ahmed SA. Fusarium species causing eumycetoma: Report of two cases and comprehensive review of the literature. Mycoses. 2017;60(3):204–12. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/myc.12590
  197. Schibli A, Goldenberger D, Krieg A, Hirschmann A, Bruder E, Osthoff M. Painless swelling of the forefoot and recurrent subcutaneous abscesses of the lower leg—Two distinct presentations illustrating the spectrum of eumycetoma in a nonendemic country. PLoS Negl Trop Dis. 2017;11(4). Available from: /pmc/articles/PMC5390975/
  198. Ahmed SA, González GM, Tirado-Sánchez A, Moreno-López LM, De Hoog S, Bonifaz A. Nigrograna mackinnonii, Not Trematosphaeria grisea (syn., Madurella grisea), Is the Main Agent of Black Grain Eumycetoma in Latin America. J Clin Microbiol. 2018;56(3). Available from: /pmc/articles/PMC5824062/
  199. Borjian Boroujeni Z, Hashemi SJ, Daie Ghazvini R, Khodavaisy S, Zareei M, Hosseinpour L, et al. Recurrent eumycetoma caused by novel species Madurella pseudomycetomatis: A case report. Med Mycol Case Rep. 2019;26:13–5.
  200. Kalatharan L, Kelley P. Eumycetoma diagnosed in urban Australia. Medical Journal of Australia. 2020;212(3):107-107.e1. Available from: https://onlinelibrary.wiley.com/doi/full/10.5694/mja2.50464
  201. Nyuykonge B, Klaassen CHW, Zandijk WHA, de Hoog GS, Ahmed SA, Desnos-Ollivier M, et al. Diagnostic implications of mycetoma derived from Madurella pseudomycetomatis isolates from Mexico. Journal of the European Academy of Dermatology and Venereology. 2020;34(8):1828–34. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16402
  202. Kaur M, Singla N, Bhalla M, Kundu R, Gulati N, Chander J. Aspergillus candidus eumycetoma with review of literature. Journal of Medical Mycology. 2021;31(3):101135.
  203. Sahu BK, Nag HL. An Illustrative Report of Three Cases of Madura Foot with Diagnostic and Treatment Features. J Orthop Case Rep. 2021;11(11):74. Available from: /pmc/articles/PMC8930322/
  204. Porte L, Khatibi S, Hajj L El, Cassaing S, Berry A, Massip P, et al. Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole. Trans R Soc Trop Med Hyg. 2006;100(9):891–4. Available from: https://pubmed.ncbi.nlm.nih.gov/16714039/
  205. Pierre Loulergue, Arnaud Hot, Eric Dannaoui, Alexiane Dallot, Sylvain Poirée, Bertrand Dupont, et al. Successful treatment of black-grain mycetoma with voriconazole – PubMed. Am J Trop Med Hyg . 2006;75(6):1106–7. Available from: https://pubmed.ncbi.nlm.nih.gov/17172376/
  206. Oddy MJ, Blundell CM, Suvarna SK, Greig JM. Mycetoma of the foot. Br J Hosp Med (Lond). 2009;70(11):658. Available from: https://pubmed.ncbi.nlm.nih.gov/20081596/
  207. Cartwright KE, Clark TW, Hussain AM, Wiselka M, Borman A, Johnson EM. Eumycetoma of the hand caused by Leptosphaeria tompkinsii and refractory to medical therapy with voriconazole. Mycopathologia. 2011;172(4):311–5. Available from: https://pubmed.ncbi.nlm.nih.gov/21567225/
  208. Gulati V, Bakare S, Tibrewal S, Ismail N, Sayani J, Baghla DPS. A Rare Presentation of Concurrent Scedosporium apiospermum and Madurella grisea Eumycetoma in an Immunocompetent Host. Case Rep Pathol. 2012;2012:1–4. Available from: https://pubmed.ncbi.nlm.nih.gov/23133772/
  209. Oliveira F de M, Unis G, Hochhegger B, Severo LC. Scedosporium apiospermum eumycetoma successfully treated with oral voriconazole: report of a case and review of the Brazilian reports on scedosporiosis. Rev Inst Med Trop Sao Paulo. 2013;55(2):121–3. Available from: https://pubmed.ncbi.nlm.nih.gov/23563766/
  210. Crabol Y, Poiree S, Bougnoux ME, Maunoury C, Barete S, Zeller V, et al. Last Generation Triazoles for Imported Eumycetoma in Eleven Consecutive Adults. PLoS Negl Trop Dis. 2014;8(10). Available from: /pmc/articles/PMC4191942/
  211. Ahmed SA, Abbas MA, Jouvion G, Al-Hatmi AMS, de Hoog GS, Kolecka A, et al. Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry. Mycoses. 2015;58(12):728–34. Available from: https://pubmed.ncbi.nlm.nih.gov/26497138/
  212. Negroni R, Tobón A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo. 2005;47(6):339–46. Available from: https://pubmed.ncbi.nlm.nih.gov/16553324/
  213. Difonzo EM, Massi D, Vanzi L, Lotti L, Agnoletti AF, Baldinotti V. Madurella mycetomatis Mycetoma Treated Successfully with Oral Posaconazole. http://dx.doi.org/101179/joc2011234234. 2013;23(4):943–4. Available from: https://www.tandfonline.com/doi/abs/10.1179/joc.2011.23.4.234
  214. Hoogervorst LA, Op De Coul LS, Ray A, De Witte PB, De Boer MGJ. Mycetoma caused by Madurella mycetomatis in immunocompromised patients – a case report and systematic literature review. J Bone Jt Infect. 2022;7(6):241. Available from: /pmc/articles/PMC9752710/
  215. Ueda Y, Matiskella JD, Golik J, Connolly TP, Hudyma TW, Venkatesh S, et al. Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: Synthesis and biological properties. Bioorg Med Chem Lett. 2003;13(21):3669–72.
  216. Fahal AH, Bakhiet SM, Mohamed ESW, Ahmed ES, Bakhiet OEH, Yousif ABA, et al. S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—top line results. Med Mycol. 2022;60(Supplement_1). Available from: https://academic.oup.com/mmy/article/60/Supplement_1/myac072S45a/6706442
  217. N’Diaye B, Dieng MT, Perez A, Stockmeyer M, Bakshi R. Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol. 2006;45(2):154–7. Available from: https://pubmed.ncbi.nlm.nih.gov/16445509/
  218. Diatta BA, Ndiaye M, Sarr L, Diatta BJM, Gueye AB, Diop A, et al. [Thoracic tumor-like fungal mycetoma: interest of large surgery with terbinafine]. J Mycol Med. 2014;24(4):351–4. Available from: https://pubmed.ncbi.nlm.nih.gov/25467818/
  219. Standish SN, Goldstein W, Stuart CR. Pedal Fungal Mass in the Midwest. J Am Podiatr Med Assoc. 2018;108(4):334–9. Available from: https://pubmed.ncbi.nlm.nih.gov/30156886/
  220. Malisiewicz B, Uhrlaß S, Nenoff P, Schöfer H. Eumycetoma due to Fusarium chlamydosporum : Case report und review of the literature. Hautarzt. 2019;70(8):612–7. Available from: https://link.springer.com/article/10.1007/s00105-019-4430-8
  221. Karrakchou B, Boubnane I, Senouci K, Hassam B. Madurella mycetomatis infection of the foot: a case report of a neglected tropical disease in a non-endemic region. BMC Dermatol. 2020;20(1). Available from: /pmc/articles/PMC6953183/
  222. Hopps S, Roach A, Yuen C, Borders E. Treatment for a eumycetoma infection caused by Aspergillus in an immunocompromised host: a case report. Transplant Infectious Disease. 2015;17(1):94–7. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/tid.12321
  223. Ong DCG, Khan R, Golledge C, Carey Smith R. Case report: Eumycetoma and mycotic arthritis of the knee caused by Arthrographis kalrae. J Orthop. 2015;12(Suppl 1):S140. Available from: /pmc/articles/PMC4674515/
  224. Criado PR, Belda Junior W, da Matta VLR. First report of cutaneous mycetoma by Paecilomyces variotii and the successful treatment with combined itraconazole and terbinafine along with resection surgeries. Australas J Dermatol. 2021;62(3):e397–9. Available from: https://pubmed.ncbi.nlm.nih.gov/33759175/
  225. Vera-Cabrera L, Cardenas-De la Garza JA, Cuellar-Barboza A, Gallardo-Rocha A, Molina-Torres CA, Escalante-Fuentes W, et al. Case Report: Coral Reef Pathogen Aspergillus sydowii Causing Black Grain Mycetoma. Am J Trop Med Hyg. 2021;104(3):871–3. Available from: https://pubmed.ncbi.nlm.nih.gov/33399044/
  226. Sigera LSM, Narangoda KUL, Dahanayake MY, Shabri ULF, Malkanthi MA, somarathne V, et al. Mycetoma due to Madurella mycetomatis. IDCases. 2020;21:e00857. Available from: /pmc/articles/PMC7283137/
  227. Dupont B, Datry A, Poirée S, Canestri A, Boucheneb S, Fourniols E. Role of a NSAID in the apparent cure of a fungal mycetoma. J Mycol Med. 2016;26(2):86–93. Available from: https://pubmed.ncbi.nlm.nih.gov/27233662/
  228. Pether JVS, Jones W, Greatorex FB, Bunting W. Acute pyogenic Pseudallescheria boydii foot infection sequentially treated with miconazole and itraconazole. J Infect. 1992;25(3):335–6. Available from: https://pubmed.ncbi.nlm.nih.gov/1335468/
  229. Turiansky GW, Benson PM, Sperling LC, Sau P, Salkin IF, McGinnis MR, et al. Phialophora verrucosa: A new cause of mycetoma. J Am Acad Dermatol. 1995;32(2):311–5.
  230. Lalchandani R, Salvi B V., D’souza P, Gugnani HC. Successful Limb Salvage in a Case of Advanced Long-Standing Eumycetoma of the Foot Using Adjunctive Local Amphotericin B Delivery Through Bioabsorbable Beads. Indian J Orthop. 2020;54(2):224–7. Available from: https://link.springer.com/article/10.1007/s43465-019-00031-3
  231. Barnetson RSC, Milne LJR. Mycetoma. British Journal of Dermatology. 1978;99(2):227–31. Available from: https://academic.oup.com/bjd/article/99/2/227/6670349
  232. Hayden G, Lapp C, Loda F. Arthritis caused by Monosporium apiospermum treated with intraarticular amphotericin B. Am J Dis Child. 1977;131(8):927. Available from: https://pubmed.ncbi.nlm.nih.gov/560796/
  233. Gündüz K, Örgüç Ş, Demireli P, Inanir I, Sürücüoglu S, Ovali GY. A case of mycetoma successfully treated with itraconazole and co-trimoxazole. Mycoses. 2006;49(5):436–8. Available from: https://pubmed.ncbi.nlm.nih.gov/16922800/
  234. Manz B, Nenoff P, Mittag M, Rytter M, Haustein UF. Schmerzhafte fußschwellung bei einem 16-jährigen Afrikaner. Hautarzt. 2001;52(7):672–6. Available from: https://link.springer.com/article/10.1007/s001050170114
  235. Gupta S, Jain K, Parmar C, Shah P, Raval RC. Mycetoma: Nonvenereal perineal lesions. Indian J Sex Transm Dis AIDS. 2010;31(1):39. Available from: /pmc/articles/PMC3140148/
  236. Sharma AM, Sharma N, Nat A, Rane M, Endy TP. Case Report: Non-Invasive Management of Madura Foot with Oral Posaconazole and Ciprofloxacin. Am J Trop Med Hyg. 2014;91(6):1259. Available from: /pmc/articles/PMC4257656/
  237. Southern PM. Mycetoma Due to Madurella Grisea Acquired in Mexico. http://dx.doi.org/101177/004947559602600420. 2016;26(4):187–8. Available from: https://journals.sagepub.com/doi/10.1177/004947559602600420?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed